TiGenix rheumatoid arthritis Phase IIa study opens third and last cohort. 01.02.12

Endosense launches TactiCath 75 force-sensing catheter, announces new results of EFFICAS clinical study. 12.01.12

AM-Pharma Announces Appointment of Russell Greig as Chairman. 12.01.12

TiGenix Reports Positive Results of ChondroCelect. Compassionate Use Program. 09.01.12